NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline
July 11, 2024 07:00 ET
|
NMD Pharma
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline Aarhus, Denmark, 11 July 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated...
Indegene Announces Strategic Collaboration with Microsoft to Help Life Sciences Companies Scale Up Generative AI Adoption and Accelerate Business Impact
July 11, 2024 02:56 ET
|
Indegene Inc
PRINCETON, N.J. and BENGALURU, India, July 11, 2024 (GLOBE NEWSWIRE) -- Indegene today announced a strategic collaboration with Microsoft to empower global life sciences companies to scale up the...
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline
July 11, 2024 01:00 ET
|
NMD Pharma
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline Aarhus, Denmark, 11 July 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated...
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
July 10, 2024 07:00 ET
|
Quell TX
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors London, UK – July 10, 2024 – Quell Therapeutics Ltd (“Quell”), a world leader in...
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
July 09, 2024 07:30 ET
|
Attovia Therapeutics, Inc.
FREMONT, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics today announced the election of Mitchell H. Gold, M.D., and Angie You, Ph.D., as independent members of its Board of...
Seyltx Announces Results of Electronic Health Record Analysis to Determine the Prevalence of Refractory Chronic Cough
July 09, 2024 07:30 ET
|
Seyltx, Inc.
- Data will be presented at the London International Cough Symposium on July 18, 2024 - 54,958,289 adult patients in the USA were analyzed for cough-related diagnoses and treatments in the EHR...
Kraig Biocraft Laboratories Announces New Spider Silk Production Contract
July 08, 2024 07:05 ET
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) signs production agreement for its recombinant spider silk technology, building on its new spider silk production hybrids success
Monthly information on share capital and company voting rights
July 05, 2024 16:30 ET
|
Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, July 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
Olon Group Announces the Acquisition of GTP Bioways Group
July 03, 2024 04:30 ET
|
Olon SpA
OLON GROUP ANNOUNCES THE ACQUISITION
OF GTP BIOWAYS GROUP
GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufa
Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication
July 03, 2024 04:00 ET
|
Pneumagen Ltd
Pneumagen has previously reported positive results from both Phase 1 and a clinical proof of concept Phase 2 Human Influenza Challenge study demonstrating the potential of NeumifilNew preclinical...